Live Breaking News & Updates on Late breaking clinical

Stay informed with the latest breaking news from Late breaking clinical on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Late breaking clinical and stay connected to the pulse of your community

Mineralys Therapeutics Selected for Oral Poster Presentation of Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

Mineralys Therapeutics Selected for Oral Poster Presentation of Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Radnor , Pennsylvania , United-states , Boston , Massachusetts , American , Tanabe-pharma , Catalys-pacific , Luke-laffin , Media-relationstom-weibleelixir-health-public-relationsphone , Drug-administration , American-heart-association

Submission Site for ISHLT 2024 Annual Meeting Abstracts Now

Accepting abstracts from researchers, clinicians, and junior faculty across all professional disciplines involved in advanced heart and lung disease and...

Prague , Praha , Hlavníesto , Czech-republic , Chicago , Illinois , United-states , Scientific-program , International-society-for-heart , Research-abstracts , International-society

Coronary Bioresorbable Scaffolds Nearly as Safe and Effective as Conventional Metal Stents for Heart Disease Patients

The work could lead to advancements and improvements in new BVS technology and future clinical use among interventional cardiologists across the United States

Paris , France-general- , France , United-states , Icahn-school-of-medicine-at-mount-sinai , European-association-of-percutaneous-cardiovascular-interventions , Drug-administration , Population-health-science , Journal-of-the-american-college-cardiology , Icahn-school , Late-breaking-clinical

Research: Bioresorbable Scaffolds Safe and Effective for Heart Disease

Research: Bioresorbable Scaffolds Safe and Effective for Heart Disease
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United-states , Paris , France-general- , France , Population-health-science , Drug-administration , European-association-of-percutaneous-cardiovascular-interventions , Journal-of-the-american-college-cardiology , Icahn-school-of-medicine-at-mount-sinai , Icahn-school , Late-breaking-clinical

Bioresorbable vascular scaffolds may be just as effective as drug-eluting metal stents for treating heart disease patients

First-generation bioresorbable vascular scaffolds (BVS) may be just as effective as drug-eluting metallic stents, which are currently the standard treatment for heart disease patients undergoing percutaneous coronary intervention (PCI).

United-states , Paris , France-general- , France , Lily-ramsey , Population-health-science , Icahn-school-of-medicine-at-mount-sinai , European-association-of-percutaneous-cardiovascular-interventions , Drug-administration , Journal-of-the-american-college-cardiology , Icahn-school , Late-breaking-clinical

Bioresorbable Scaffolds Almost as Safe as Metal Stents for Heart Patients

Bioresorbable Scaffolds Almost as Safe as Metal Stents for Heart Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Westchester , New-york , United-states , Florida , Long-island , Paris , France-general- , France , Health-system , Journal-of-the-american-college-cardiology , Population-health-science

Travere Therapeutics Announces Late-Breaker Presentations of the Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy at the ISN World Congress of Nephrology and NKF Spring Clinical Meetings 2023

SAN DIEGO, March 23, 2023 -- Travere Therapeutics, Inc. today announced that the interim analysis of efficacy and safety data from the ongoing Phase 3 PROTECT Study evaluating... | March 23, 2023

Japan , Bangkok , Krung-thep-mahanakhon , Thailand , United-states , Nivi-nehra , Naomi-eichenbaum , Company-annual-report-on-form , European-union , Exchange-commission , Nasdaq , Corporate-communications

Travere Therapeutics Announces Late-Breaker Presentations of the Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy at the ISN World Congress of Nephrology and NKF Spring Clinical Meetings 2023

Travere Therapeutics Announces Late-Breaker Presentations of the Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy at the ISN World Congress of Nephrology and NKF Spring Clinical Meetings 2023
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Japan , Bangkok , Krung-thep-mahanakhon , Thailand , United-states , Nivi-nehra , Naomi-eichenbaum , World-congress , Exchange-commission , Company-annual-report-on-form , Travere-therapeutics-inc , Nasdaq

Transdermal Troponin Sensor May Speed Diagnosis in MI

The device, a wrist-worn sensor that uses infrared light to detect the presence and concentration of cardiac troponin-I in the blood through the skin, predicted levels with 90% accuracy within 5 minutes.

New-york , United-states , Boston , Massachusetts , India , New-jersey , New-brunswick , Jim-cheng , James-januzzi , Parthop-sengupta , Rutgers-robert-wood-johnson-medical-school , Technologies-inc

Elite Athletes With Genetic Heart Disease Can Return to Play

Athletes with a diagnosed genetic heart disease should not automatically be banned from participating in elite-level sports, as has previously been recommended, a new study suggests.

Minnesota , United-states , Mayo-clinic-in-rochester , Michigan , Massachusetts , Eugene-chung , James-sawalla-guseh , Katherinea-martinez , Michael-ackerman , Scientific-session-world-congress , Vascular-institute , American-college-of-cardiology